Back to search

Article

Utility of polygenic risk scores in diagnostic genetic testing for dilated cardiomyopathy

2026-01-22

Abstract excerpt

Dilated cardiomyopathy (DCM) is a major driver of heart failure and transplantation. Despite its strong genetic basis, clinical genetic testing identifies pathogenic/likely pathogenic (P/LP) variants in only about one-third of cases. Genome-wide association studies (GWAS) indicate that common variants also contribute to genetic risk, but utility of polygenic risk score (PRS) for diagnostic testing is unclear. We d...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
31562726-43e2-5a5b-93f5-fb3a27010290
DOI
10.64898/2026.01.20.26344484
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Utility of polygenic risk scores in diagnostic genetic testing for dilated cardiomyopathyDOI 10.64898/2026.01.20.26344484
Select a neighboring publication to make it the new centre.